Concepedia

Ananthsrinivas Chakilam

AC

5

Publications

589

Citations

5

H-Index

2003

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Northeastern University

Ananthsrinivas Chakilam is an author at Vertex Pharmaceuticals (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

MedicineImmunologyPharmacologyNanomedicineImmunotherapyAllergyApoptosisAutophagyCell DeathEngineering

Publications per year

2003–2017

5

Publications

5

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

Anatoly N. Lukyanov, Tamer Elbayoumi, Ananthsrinivas Chakilam et al. · Journal of Controlled Release · 2004 · 293 citations

Nanomedicine, Nanotherapeutics, Immunology +3

PEG-PE/Phosphatidylcholine Mixed Immunomicelles Specifically Deliver Encapsulated Taxol to Tumor Cells of Different Origin and Promote their Efficient Killing

Zhe Gao, Anatoly N. Lukyanov, Ananthsrinivas Chakilam et al. · Journal of drug targeting · 2003 · 103 citations

Peg Block, Apoptosis, Immunology +17

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 87 citations

Immunology, Immunologic Mechanism, Janus Tyrosine Kinases +16

Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective

Lorna Ewart, Kristin Fabre, Ananthsrinivas Chakilam et al. · Experimental Biology and Medicine · 2017 · 85 citations · Full text

Tissue Engineering, Pharmaceutical Industry Perspective, Pharmaceutical Research +21

Telaprevir‐based treatment effects on hepatitis C virus in liver and blood

Andrew H. Talal, Rositsa B. Dimova, Eileen Z. Zhang et al. · Hepatology · 2014 · 21 citations · Full text

Rows per page

1–5 of 5